Citations

Showing 10 of 108083 citations.

Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
Geramita, Emily , Bastacky, Melissa, Cohen, Jessica B, Shallis, Rory M. , Litzow, Mark R. , Im, Annie , Wang, Hong , Bastacky, Melissa L. , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6187-6188

10.1182/blood-2022-170647 Get It

Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome
Pardanani, Animesh , Tefferi, Ayalew , Singh, Amritpal , Al‐Kali, Aref , Patnaik, Mrinal M. , Begna, Kebede, Elliott, Michelle A. , Khera, Nandita , Palmer, Jeanne , Gangat, Naseema , Kelemen, Katalin, Reichard, Kaaren K. , Hogan, William J. , Orazi, Attilio , Chen, Dong

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6872-6873

10.1182/blood-2022-167720 Get It

ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Hill, Brian T. , Maris, Michael, Byrne, Michael , Pagel, John M. , Zheng, Yan , Kanska, Justyna, Zhang, Wangshu , Masouleh, Behzad Kharabi, Granados, Enrique , Ibarz, Javier Pinilla, Davids, Matthew S. , Kenderian, Saad S. , Flinn, Ian W. , Ghia, Paolo , Bartlett, Nancy L.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7454-7456

10.1182/blood-2022-167868 Get It

Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603

10.1182/blood-2022-167405 Get It

A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis
Patel, Krish , Tilly, Hervé , Ghesquières, Hervé , Collela, Jean Marc Schiano de, Chanan‐Khan, Asher , Bouabdallah, Kamal , Long, Meixiao, Clynes, Raphael , Kanodia, Jitendra , Bao, Lei , Ding, Ying , Jin, Jianhua , Ainsworth, William B., Garcha, Raman, Kye, Steve, Patel, Krish , Riedell, Peter A. , Ahmed, Sairah , Michot, Jean‐Marie , Tessoulin, Benoit , Iyengar, Sunil , Bao, Lei, Phillips, Tycel

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9470-9472

10.1182/blood-2022-159586 Get It

Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma
Yeh, Su‐Peng , Gkasiamis, Argyrios, Patah, Poliana, Patel, Arpankumar , Nowakowski, Grzegorz S. , Westin, Jason R. , Martı́n, Alejandro , Hoffmann, Marc Steven , Vassilakopoulos, Theodoros P. , Li, Ju

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9475-9477

10.1182/blood-2022-162774 Get It

TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799

10.1182/blood-2022-165859 Get It

The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification
Foran, James M. , Tandra, Anand, Mattour, Ahmad, Perkins, Andrew C. , Rodríguez‐Macías, Gabriela , Sibai, Hassan , Sun, Yan , Potluri, Jalaja , Harb, Jason G., How, Jonathan, Perkins, Andrew C , Passamonti, Francesco , Stefano, Valerio De , Fox, María Laura , McMullin, Mary Frances , Qin, Qin

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 583-585

10.1182/blood-2022-157949 Get It